Movement Alert｜JOINN Rises 5.16% in Regular Trading, CXO Sector Rebounds Collectively Ahead of Mid-Term Results

Market Focus

Yesterday

On August 25, JOINN rose 5.16% in regular trading, trading at 25.24 HKD/share, with turnover of 74.29 million HKD. The stock rebounded sharply following the previous session's 5.85% decline, driven by a broad-based recovery across the CXO sector.

On the news front, the company is scheduled to hold a board meeting on August 28 to review and approve its interim results for the six months ended June 30. The upcoming earnings release has become a focal point, with earlier disclosures indicating expected first-half revenue of approximately 669-739 million yuan and net profit of 600-900 million yuan, primarily driven by positive fair value changes in biological assets. Meanwhile, the company reported a backlog of 3.1 billion yuan as of Q1-end, with non-human primate experimental animal prices and contract signing prices both showing recovery, reinforcing industry upswing signals.

Within the Life Sciences Tools & Services sector, peers rallied in tandem: Wuxi XDC up 11.6%, Insilico up 11.09%, Genscript Bio up 6.74%, Wuxi Bio up 4.63%, and Wuxi AppTec up 1.57%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/news/1101479405"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1101479405\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1101479405?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-25 13:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101479405","market":"us","top_or_hot":-1,"title":"Movement Alert｜JOINN Rises 5.16% in Regular Trading, CXO Sector Rebounds Collectively Ahead of Mid-Term Results","media":"Market Focus","content":"<p><p>On August 25, JOINN rose 5.16% in regular trading, trading at 25.24 HKD/share, with turnover of 74.29 million HKD. The stock rebounded sharply following the previous session's 5.85% decline, driven by a broad-based recovery across the CXO sector.</p><p>On the news front, the company is scheduled to hold a board meeting on August 28 to review and approve its interim results for the six months ended June 30. The upcoming earnings release has become a focal point, with earlier disclosures indicating expected first-half revenue of approximately 669-739 million yuan and net profit of 600-900 million yuan, primarily driven by positive fair value changes in biological assets. Meanwhile, the company reported a backlog of 3.1 billion yuan as of Q1-end, with non-human primate experimental animal prices and contract signing prices both showing recovery, reinforcing industry upswing signals.</p><p>Within the Life Sciences Tools & Services sector, peers rallied in tandem: Wuxi XDC up 11.6%, Insilico up 11.09%, Genscript Bio up 6.74%, Wuxi Bio up 4.63%, and Wuxi AppTec up 1.57%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜JOINN Rises 5.16% in Regular Trading, CXO Sector Rebounds Collectively Ahead of Mid-Term Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜JOINN Rises 5.16% in Regular Trading, CXO Sector Rebounds Collectively Ahead of Mid-Term Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-25 13:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 25, JOINN rose 5.16% in regular trading, trading at 25.24 HKD/share, with turnover of 74.29 million HKD. The stock rebounded sharply following the previous session's 5.85% decline, driven by a broad-based recovery across the CXO sector.</p><p>On the news front, the company is scheduled to hold a board meeting on August 28 to review and approve its interim results for the six months ended June 30. The upcoming earnings release has become a focal point, with earlier disclosures indicating expected first-half revenue of approximately 669-739 million yuan and net profit of 600-900 million yuan, primarily driven by positive fair value changes in biological assets. Meanwhile, the company reported a backlog of 3.1 billion yuan as of Q1-end, with non-human primate experimental animal prices and contract signing prices both showing recovery, reinforcing industry upswing signals.</p><p>Within the Life Sciences Tools & Services sector, peers rallied in tandem: Wuxi XDC up 11.6%, Insilico up 11.09%, Genscript Bio up 6.74%, Wuxi Bio up 4.63%, and Wuxi AppTec up 1.57%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06127","symbol_name":"昭衍新药","start_time":0,"source_url":"","article_id":"1101479405","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101479405","pubTimestamp":1787634270,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 25, JOINN rose 5.16% in regular trading, trading at 25.24 HKD/share, with turnover of 74.29 million HKD. The stock rebounded sharply following the previous session's 5.85% decline, driven...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06127":"昭衍新药"},"translate_title":"走势警报|JOINN常规交易上涨5.16%，CXO板块在中期业绩公布前集体反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06127":1},"content_text":"On August 25, JOINN rose 5.16% in regular trading, trading at 25.24 HKD/share, with turnover of 74.29 million HKD. The stock rebounded sharply following the previous session's 5.85% decline, driven by a broad-based recovery across the CXO sector.On the news front, the company is scheduled to hold a board meeting on August 28 to review and approve its interim results for the six months ended June 30. The upcoming earnings release has become a focal point, with earlier disclosures indicating expected first-half revenue of approximately 669-739 million yuan and net profit of 600-900 million yuan, primarily driven by positive fair value changes in biological assets. Meanwhile, the company reported a backlog of 3.1 billion yuan as of Q1-end, with non-human primate experimental animal prices and contract signing prices both showing recovery, reinforcing industry upswing signals.Within the Life Sciences Tools & Services sector, peers rallied in tandem: Wuxi XDC up 11.6%, Insilico up 11.09%, Genscript Bio up 6.74%, Wuxi Bio up 4.63%, and Wuxi AppTec up 1.57%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}